A, Y., T, T., Y, K., K, T., S, Y., M, H., . . . T, A. (2024). Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy. Internal medicine (Tokyo, Japan), 63(14), 2043. https://doi.org/10.2169/internalmedicine.2847-23
Chicago Style (17th ed.) CitationA, Yanagisawa, Takimoto T, Kurahara Y, Tsuyuguchi K, Yoshida S, Hirose M, Inoue Y, and Arai T. "Lymphangioleiomyomatosis Showing the Development of Mycobacterium Abscessus Subsp. Massiliense Infection During Sirolimus Therapy." Internal Medicine (Tokyo, Japan) 63, no. 14 (2024): 2043. https://doi.org/10.2169/internalmedicine.2847-23.
MLA (9th ed.) CitationA, Yanagisawa, et al. "Lymphangioleiomyomatosis Showing the Development of Mycobacterium Abscessus Subsp. Massiliense Infection During Sirolimus Therapy." Internal Medicine (Tokyo, Japan), vol. 63, no. 14, 2024, p. 2043, https://doi.org/10.2169/internalmedicine.2847-23.